|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.830 USD | -0.78% |
|
-1.03% | -70.10% |
| 08-03 | Plus Therapeutics, Inc. will Change its Name to Cerenome | CI |
| 08-03 | Plus Therapeutics, Inc. will Change its Ticker to CNSY from PSTV | CI |
Company Valuation: Cerenome, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 16.13 | 10.65 | 7.915 | 6.781 | 70.4 | 26.36 | - | - |
| Change | - | -33.96% | -25.69% | -14.33% | 938.3% | -62.56% | - | - |
| Enterprise Value (EV) | 16.13 | 10.65 | 7.915 | 6.781 | 70.4 | 26.36 | 26.36 | 26.36 |
| Change | - | -33.96% | -25.69% | -14.33% | 938.3% | -62.56% | 0% | 0% |
| P/E | -0.95x | -0.41x | -0.41x | -0.59x | -44.2x | -0.98x | -1.6x | -13.1x |
| PBR | 1.5x | 1.29x | - | - | - | - | - | - |
| PEG | - | 0x | 0x | 0x | 0.4x | -0x | 0x | 0.1x |
| Capitalization / Revenue | - | 47.6x | 1.61x | 1.16x | 13.5x | 4.19x | 1.38x | 0.58x |
| EV / Revenue | - | 0x | 0x | 0x | 0x | 4.19x | 1.38x | 0.58x |
| EV / EBITDA | -0x | -0x | -0x | -0x | -0x | -1.14x | -1.57x | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -0.97x | -1.39x | -4.74x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -416.2 | -288.7 | -106 | -48.75 | -0.29 | -3.922 | -2.395 | -0.2933 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | 0.224 | 4.913 | 5.824 | 5.213 | 6.295 | 19.14 | 45.31 |
| EBITDA 1 | -11.85 | -19.09 | -12.69 | -13.42 | -13.31 | -23.1 | -16.8 | - |
| EBIT 1 | -12.49 | -19.71 | -13.32 | -14.7 | -15.3 | -27.27 | -18.95 | -5.567 |
| Net income 1 | -13.4 | -20.28 | -13.32 | -12.98 | -22.39 | -26.8 | -18.45 | -5.074 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 393.750 | 118.875 | 43.752 | 28.750 | 12.808 | 3.830 | 3.830 | 3.830 |
| Nbr of stocks (in thousands) | 41 | 89.6 | 181 | 236 | 5,497 | 6,883 | - | - |
| Announcement Date | 24/02/22 | 23/02/23 | 05/03/24 | 27/03/25 | 12/03/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.98x | - | - | - | 26.36M | |
| 33.6x | 6x | 17.84x | 0.95% | 49.47B | |
| -22.52x | 310.02x | -21.74x | -.--% | 43.61B | |
| 46.21x | 5.25x | 28.83x | -.--% | 39.6B | |
| 30.74x | 3.05x | 13.16x | -.--% | 39.29B | |
| 30.33x | 8.75x | 21.99x | 0.38% | 32.43B | |
| 33.59x | 5.5x | 24.99x | -.--% | 16.49B | |
| 23.22x | 2.04x | 8.82x | 1.16% | 14.01B | |
| 65.72x | 3.81x | 14.78x | -.--% | 12.77B | |
| Average | 26.66x | 43.05x | 13.58x | 0.31% | 27.52B | |
| Weighted average by Cap. | 25.92x | 58.94x | 12.24x | 0.31% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CNSY Stock
- Valuation Cerenome, Inc.
Select your edition
All financial news and data tailored to specific country editions
